| |
|
|
|
Sutro Biopharma Inc  
|
|
10.32 -0.03 (-0%) |
09-24 16:00 |
|
Open: |
10.31 |
Pre close: |
10.35 |
Target:
|
13.85
|
|
High: |
10.53 |
Low: |
10.11 |
Resistance:
|
11.86
13.91
|
|
Volume: |
148,956 |
Market Cap: |
370M |
Support:
|
8.54
7.11
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.90
 |
MACD |
MACD(12,26):
|
0.32 |
|
MA(20): |
11.08  |
Signal(12,26,9): |
0.53 |
|
MA(100): |
9.39 |
Stochastic Oscillator |
%K(14,3):
|
14.94 |
|
MA(250): |
9.95 |
%D(3): |
26.73 |
|
Average Volume(K) |
3-Month: |
33870
|
52-Week |
High:
|
13.91 |
|
10-Days: |
56677 |
Low: |
6.00 |
|
RSI |
RSI(14):
|
48.14 |
Change(%): |
10.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.710 |
Return on Equity (ttm) |
-10.7 |
Shares Out. (M) |
35.88 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.5 |
Shares Float (M) |
20.63 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
21.16 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-10.0 |
% Held by Institutions |
69.52 |
|
Forward EPS |
-2.430 |
Gross Profit (p.s.) |
-0.638 |
Shares Short (K) |
752 |
|
Book Value (p.s.) |
5.760 |
EBITDA (p.s.) |
-1.690 |
P/E |
-14.54 |
|
Sales Per Share |
1.120 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.79 |
|
Profit Margin |
-43.34 |
Operating Cash Flow
(M) |
-60.51 |
P/S |
9.21 |
|
Operating Margin |
-162.33 |
Levered Free Cash Flow
(M) |
-24.04 |
P/CF |
-6.12 |
|
|
|
|
|
|
